Related Experiment Video

Updated: Aug 13, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Do infectious diseases drive MHC diversity?

K J Jeffery1, C R Bangham

  • 1Department of Immunology, Imperial College School of Medicine at St Mary's, Norfolk Place, London W2 1PG, UK.

Microbes and Infection
|October 6, 2000
PubMed

Insights

The major histocompatibility complex (MHC) helps the immune system fight infections. Extraordinary MHC diversity is driven by infectious diseases, which act as a key evolutionary force.

Area of Science:

  • Immunology
  • Evolutionary Biology
  • Genetics

Background:

  • The immune system relies on the major histocompatibility complex (MHC) to distinguish self from non-self, identifying and eliminating pathogens.
  • MHC molecules present pathogen-derived peptides to T cells, initiating an immune response.

Purpose of the Study:

  • To explore the role of infectious diseases as a primary driver of major histocompatibility complex (MHC) diversity.
  • To understand the evolutionary pressures shaping MHC gene polymorphism.

Main Methods:

  • Review of existing literature on MHC function and evolution.
  • Analysis of population genetics data related to MHC genes.
  • Comparative genomics studies.

Main Results:

  • The major histocompatibility complex (MHC) plays a critical role in pathogen recognition and immune response.
  • Evidence suggests that infectious diseases are a significant selective pressure maintaining high MHC diversity.
  • High MHC diversity enhances the ability of a population to resist a wide range of pathogens.

Conclusions:

  • Infectious diseases are a major evolutionary force shaping the extraordinary diversity observed in the major histocompatibility complex (MHC).
  • Understanding MHC diversity is crucial for fields ranging from evolutionary biology to vaccine development and disease resistance.

More Related Videos

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

Related Concept Videos

Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Antigen Processing Pathways01:31

Antigen Processing Pathways

MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...